KRAS and cancer: Samples with the highest quartile of FOXM1 and MYBL2 expression possessed a significantly greater number of cancer-specific enhancer links, however, KRAS or EGFR genetic alteration status was not associated with a significant difference in the number of these links regardless of the FOXM1 and MYBL2 expression level (S7B Fig).